Superoxide Dismutase-1 Intracellular Content in T Lymphocytes Associates with Increased Regulatory T Cell Level in Multiple Sclerosis Subjects Undergoing Immune-Modulating Treatment
Authors:
- Valentina RubinoVRValentina Rubino
- Anna Teresa PalatucciAPAnna Teresa Palatucci
- Giuliana La RosaGiuliana La Rosa
- Angela GiovazzinoAGAngela Giovazzino
- Francesco ArutaFAFrancesco Aruta
- Simona DamianoSDSimona Damiano
- Flavia CarrieroFCFlavia Carriero
- Mariarosaria SantilloMSMariarosaria Santillo
- Rosa IodiceRIRosa Iodice
- Paolo MondolaPMPaolo Mondola
- Giuseppina RuggieroGRGiuseppina Ruggiero
- Giuseppe TerrazzanoGTGiuseppe Terrazzano
Open Access
- 3 December 2021
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 10 (12) , 1940
Abstract
Reactive oxygen species (ROS) participate in the T-cell activation processes. ROS-dependent regulatory networks are usually mediated by peroxides, which are more stable and able to freely migrate inside cells. Superoxide dismutase (SOD)-1 represents the major physiological intracellular source of peroxides. We found that antigen-dependent activation represents a triggering element for SOD-1 production and secretion by human T lymphocytes. A deranged T-cell proinflammatory response characterizes the pathogenesis of multiple sclerosis (MS). We previously observed a decreased SOD-1 intracellular content in leukocytes of MS individuals at diagnosis, with increasing amounts of such enzyme after interferon (IFN)-b 1b treatment. Here, we analyzed in depth SOD-1 intracellular content in T cells in a cohort of MS individuals undergoing immune-modulating treatment. Higher amounts of the enzyme were associated with increased availability of regulatory T cells (Treg) preferentially expressing Foxp3-exon 2 (Foxp3-E2), as described for effective Treg. In vitro administration of recombinant human SOD-1 to activated T cells, significantly increased their IL-17 production, while SOD-1 molecules lacking dismutase activity were unable to interfere with cytokine production by activated T cells in vitro. Furthermore, hydrogen peroxide addition was observed to mimic, in vitro, the SOD-1 effect on IL-17 production. These data add SOD-1 to the molecules involved in the molecular pathways contributing to re-shaping the T-cell cytokine profile and Treg differentiation.Keywords
Funding Information
- Associazione Italiana Sclerosi Multipla (2017/R/23 and financed or co-financed with the ‘5 per mille’ public funding)
- Ministero dell’Istruzione, dell’Università e della Ricerca (Programma Operativo Nazionale “Ricerca e Innovazione” 2014-2020 (PON “R&I” 2014-2020), for the project “Prodotti innovativi ad alto contenuto biotecnologico- INBIOMED”)
This publication has 43 references indexed in Scilit:
- Disease Tolerance as a Defense StrategyScience, 2012
- Radical changes in multiple sclerosis pathogenesisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromesBritish Journal of Haematology, 2009
- Superoxide dismutase 1 (SOD1) is essential for H 2 O 2 -mediated oxidation and inactivation of phosphatases in growth factor signalingProceedings of the National Academy of Sciences, 2008
- IMMUNOLOGY OF MULTIPLE SCLEROSISAnnual Review of Immunology, 2005
- Hydrogen peroxide as second messenger in lymphocyte activationNature Immunology, 2002
- Subcellular Distribution of Superoxide Dismutases (SOD) in Rat LiverJournal of Biological Chemistry, 2001
- SUPEROXIDE RADICAL AND SUPEROXIDE DISMUTASESAnnual Review of Biochemistry, 1995
- Cellular Tolerance as a Dynamic State of the Adaptable LymphocyteImmunological Reviews, 1993